Results 51 to 60 of about 372,480 (259)

Topical Corticosteroids

Eurasian Journal of Medicine, 2019
-
Şevki Özdemir, Muammer Parlak, Gönül Ergenekon   +2 more
doaj  

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy

Frontiers in Endocrinology, 2021
Graves’ disease (GD) is an organ-specific autoimmune disorder of the thyroid, which is characterized by circulating TSH-receptor (TSH-R) stimulating antibodies (TSAb), leading to hyperthyroidism.
Poupak Fallahi, Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Armando Patrizio, Stefania Camastra, Mario Miccoli, Gabriella Cavallini, Salvatore Benvenga, Salvatore Benvenga, Salvatore Benvenga, Alessandro Antonelli   +12 more
doaj   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Corticosteroids

, 2022
Corticosteroids are among the most widely prescribed drug classes globally. The corticosteroid market is projected to be worth more than USD 10 billion annually. Corticosteroids, which include glucocorticoids and mineralocorticoids, are synthetic analogs
Parmar, Mayur S, Padda, Inderbir
core   +2 more sources

Role of Corticosteroids in Drug-Induced Liver Injury. A Systematic Review

Frontiers in Pharmacology, 2022
Introduction: Apart from cessation of the implicated agent leading to drug-induced liver injury (DILI), there is no standard therapy for DILI. Corticosteroids have been used in DILI, although their efficacy is unclear.
Einar S. Björnsson, Einar S. Björnsson, Vesna Vucic, Guido Stirnimann, Mercedes Robles-Díaz   +4 more
doaj   +1 more source

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source

Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands [PDF]

, 2006
Objective: Inhaled corticosteroids (ICS) are widely used in the treatment of asthma. We studied the suspected adverse drug reactions (sADRs) reported during the use of ICS in the Netherlands. Methods: In the Netherlands, health professionals and patients
van Puijenbroek, E; id_orcid, van Puijenbroek, E, de Vries, T.W., de Jong-van den Berg, L.T.W., de Langen-Wouterse, J J, L. T. W. de Jong-Van den Berg, T. W. de Vries, E. J. Duiverman, J. J. de Langen-Wouterse, de Jong-Van den Berg, L T W, Langen-Wouterse, J.J., van Puijenbroek, E., Duiverman, E.J., Duiverman, E J, E. van Puijenbroek   +14 more
core   +1 more source

Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane, Anna Capasso, Chiara Arpaia, Adele D’Amico, Emilio Albamonte, Federica Trucco, Maria Sframeli, Riccardo Masson, Francesca Magri, Luca Bello, Romina Venditti, Claudia Dosi, Michela Catteruccia, Michele Tosi, Claudio Bruno, Sonia Messina, Giacomo Comi, Elena Pegoraro, Valeria A. Sansone, Eugenio Mercuri   +19 more
wiley   +1 more source

Safety for the Rhinologist in the Age of COVID-19: Mask Use, Nasal Corticosteroids, Saline Irrigation, and Endoscopic Procedures – Literature Review

International Archives of Otorhinolaryngology, 2022
Introduction Coronavirus disease 2019 (COVID-19) has claimed millions of lives. Adequate protection of the professionals involved in patient care is essential in the battle against this disease.
Eduardo Macoto Kosugi, Jonatas Figueiredo Villa, Henrique Faria Ramos, Gabriela Ricci Luz-Matsumoto, Thiago Luis Infanger Serrano, Carlos Augusto Correia de Campos, Carolina Cincurá Barreto, Clara Mônica Lima, Marco Aurélio Fornazieri, Otavio Piltcher, Marcus Miranda Lessa, Fabrizio Ricci Romano   +11 more
doaj   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source